Serum Sickness and Delayed Drug Reactions nursing care: what to assess and what to do

What it is and why it happens

Serum sickness is a type III hypersensitivity reaction. Antigen-antibody complexes form in the circulation and deposit in small vessels, joints and the skin, triggering complement activation and local inflammation. This is fundamentally different from the IgE-mediated, immediate mechanism behind anaphylaxis.

The classic trigger is heterologous antiserum: antivenom, antitoxin, or antithymocyte globulin, where the therapeutic protein itself is foreign and provokes antibody formation. Beta-lactam antibiotics, particularly cefaclor and penicillins, are the more common cause seen on the wards now. Monoclonal antibodies and other biologics can also trigger it.

The delay matters. Symptoms do not appear on first exposure until the immune system has had time to mount an antibody response and form complexes, typically 1 to 3 weeks after the drug or serum was given. A patient can be well past discharge before it starts.

How it presents — what you will actually see

Fever is usually the first sign, often low-grade and easy to dismiss as something else entirely. It is followed within a day or two by a rash, classically urticarial or morbilliform, sometimes starting at injection sites or areas of pressure like the waistband or axillae before spreading.

Arthralgia is the third piece of the triad and tends to be symmetric, affecting the hands, knees and feet. Patients describe stiffness and pain rather than visible joint swelling. Lymphadenopathy, malaise and mild proteinuria can accompany the core triad.

The presentation is easy to mistake for a viral illness or a new drug allergy if the timeline is not taken seriously. The single most useful assessment question is what the patient received 1 to 3 weeks ago, not what they took today.

Nursing assessment priorities

Take a precise medication and exposure history reaching back 3 weeks, not just the current med list. Ask specifically about antivenom, IV antibiotics, or any infusion given during a prior admission or ED visit.

Assess and document the rash distribution, joint involvement, and vital signs, with particular attention to fever pattern. Check urine for protein and blood, since immune complex deposition can affect the kidneys and mild glomerulonephritis is a recognised complication.

Distinguish this from anaphylaxis on assessment: no airway compromise, no acute hypotension, no stridor, no onset within minutes of exposure. Confusing the two changes the entire management pathway, so this distinction should be made and documented early, not assumed.

Interventions and what to do first

Epinephrine has no role here. This is the point that trips learners on the exam and at the bedside: an anaphylaxis protocol answer is wrong for serum sickness because there is no mast cell degranulation driving airway or cardiovascular collapse.

First-line management is antihistamines for pruritus and rash, NSAIDs for arthralgia and fever, and corticosteroids for more severe or persistent cases. If the causative agent is still being administered, stop it and notify the prescriber immediately.

Monitor renal function and urine output if proteinuria was found on initial assessment. Most cases are self-limiting over 1 to 2 weeks once the trigger is removed and symptoms are controlled, but the patient needs to be told that and reassessed, not just medicated and discharged.

Complications to watch for

Glomerulonephritis from immune complex deposition in the kidney is the complication most worth tracking. It is usually mild and self-resolving but warrants a repeat urinalysis before the patient is considered fully recovered.

Rarely, vasculitis develops from complex deposition in vessel walls, presenting as palpable purpura or more severe organ involvement. Peripheral neuropathy has also been reported in a small number of cases, thought to relate to immune complex deposition near peripheral nerves.

Re-exposure to the same causative agent risks a faster, more severe recurrence, since the patient already has circulating antibody. Flag the trigger clearly in the allergy or adverse-reaction section of the record, not just in a progress note.

Patient teaching before discharge

Explain the timeline clearly: symptoms may still worsen over the next few days even as treatment starts, and full resolution can take 1 to 2 weeks. Patients who expect immediate improvement often present again out of concern that treatment is not working.

Teach the difference between this reaction and a true drug allergy in plain terms so the patient can explain it accurately to future clinicians. Confirm the causative agent is documented and understood before they leave, and advise they mention it to any prescriber before receiving the same antibiotic class or biologic again.